Vicore Pharma Holding AB (publ) VCRE

Full chart Compare
Set alert

Price alert · VCRE

All alert types
9.55 USD +0.22 (+2.36%)

Nov 4, 2026, 3:54 PM EST

9.44 Day range 9.74
7.88 52-week range 17.80
YTD
-41.23%
1 year
-41.23%

Financial health

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -68.1×
FY 2021: -31.2×FY 2022: -44.5×FY 2023: -51.1×FY 2024: -163×FY 2025: -68.1×
FY 2021 5y median -51.1× FY 2025
P/S 941×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 22.5×FY 2025: 941×
FY 2021 5y median 0.0× FY 2025
P/B 3.3×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 3.3×
FY 2021 5y median 0.0× FY 2025
P/FCF -9.6×
FY 2021: -3.9×FY 2022: -4.0×FY 2023: -6.3×FY 2024: -14.9×FY 2025: -9.6×
FY 2021 5y median -6.3× FY 2025
EV/EBITDA -6.3×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -6.3×
FY 2021 5y median 0.0× FY 2025
EV/Sales 790×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 790×
FY 2021 5y median 0.0× FY 2025
FCF Yield -10.5%
FY 2021: -25.8%FY 2022: -24.8%FY 2023: -15.8%FY 2024: -6.7%FY 2025: -10.5%
FY 2021 5y median -15.8% FY 2025

Profitability

Gross Margin 100.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin -11905.8%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -174.1%FY 2025: -11905.8%
FY 2021 5y median 0.0% FY 2025
Net Margin -12509.1%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -154.2%FY 2025: -12509.1%
FY 2021 5y median 0.0% FY 2025
ROE -43.6%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -43.6%
FY 2021 5y median 0.0% FY 2025
ROIC -41.3%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -41.3%
FY 2021 5y median 0.0% FY 2025
ROA -39.2%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -39.2%
FY 2021 5y median 0.0% FY 2025

Growth (YoY)

Revenue -96.5%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -96.5%
FY 2021 FY 2025
Operating Income -138.7%
FY 2021: 0.0%FY 2022: -792.0%FY 2023: -10.6%FY 2024: 40.8%FY 2025: -138.7%
FY 2021 FY 2025
EPS (diluted) -100.0%
FY 2021: 0.0%FY 2022: 19.1%FY 2023: 15.8%FY 2024: 65.6%FY 2025: -100.0%
FY 2021 FY 2025
Free Cash Flow -127.8%
FY 2021: 0.0%FY 2022: -14.8%FY 2023: 17.6%FY 2024: 33.9%FY 2025: -127.8%
FY 2021 FY 2025

Financial Health

Current Ratio 10.3×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 10.3×
FY 2021 5y median 0.0× FY 2025
Quick Ratio 10.3×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 10.3×
FY 2021 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.2×
FY 2021 5y median 0.0× FY 2025
Interest Coverage -7574×
FY 2021: 0.0×FY 2022: -36341×FY 2023: -160753×FY 2024: -23795×FY 2025: -7574×
FY 2021 5y median -23795× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31